Dong Wang
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CIETAI and Sequential Radiotherapy in Squamous Lung Cancer (NCT05892237) | Dong Wang | 2023-07-01 |
| TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer (NCT04471480) | Dong Wang | 2020-09-01 |
| Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC (NCT04063449) | Dong Wang | 2019-08-20 |
| Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors (NCT04060472) | Dong Wang | 2019-08-20 |
Track Dong Wang automatically
Every clearance here is in the API, with alerts when new ones post.